---
$id: https://graph.org.ai/products/commodity/51201810
$type: Product
source: UNSPSC
code: "51201810"
title: "Galsulfase"
class: "51201800"
classTitle: "Immunostimulating agents"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Galsulfase

**UNSPSC Code**: 51201810
**Class**: [Immunostimulating agents](Immunostimulating agents.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an enzyme replacement preparation with the molecular formula C2529H3843N689O716S16, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 59UA429E5G, more generally known as galsulfase. European Medicines Agency schedules galsulfase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21229. The term GALSULFASE is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 19, no. 3, 2005, list 54. Most nations schedule galsulfase under HS 35079090 and SITC 51691. As of Q4 2014, GALSULFASE remains the US FDA Preferred Term for this commodity. Galsulfase bears US NLM identifiers UMLS ID C1615657 and NCI Concept Code C74207. SMILES: NONE.

